RSPO3 and fatty liver disease: In addition, recent studies have implicated HNF4A and PROX1-AS1 in insulin resistance and T2D [66,67], whereas loci harboring FAM13A, RSPO3, and EBPL have been associated with body fat distribution and hepatic steatosis [68,69,70].